| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2001;38:210.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Pharmacology (H.E.S., F.Z., A.N., M.S., A.K., N.G.A.) and Pathology (A.E.), New York Medical College, Valhalla; Rockefeller University (M.S., A.K., N.G.A.), New York, NY; and Department of Pediatrics, Stanford University School of Medicine (X.N., P.D.), Calif.
Correspondence to Professor Nader G. Abraham, Department of Pharmacology, New York Medical College, Valhalla, NY 10595. E-mail nader_abrham{at}nymc.edu
Abstract Heme oxygenase (HO) catalyzes the conversion of heme to biliverdin, with release of free iron and carbon monoxide. Both heme and carbon monoxide have been implicated in the regulation of vascular tone. A retroviral vector containing human HO-1 cDNA (LSN-HHO-1) was constructed and subjected to purification and concentration of the viral particles to achieve 5x109 to 1x1010 colony-forming units per milliliter. The ability of concentrated infectious viral particles to express human HO-1 (HHO-1) in vivo was tested. A single intracardiac injection of the concentrated infectious viral particles (expressing HHO-1) to 5-day-old spontaneously hypertensive rats resulted in functional expression of the HHO-1 gene and attenuation of the development of hypertension. Rats expressing HHO-1 showed a significant decrease in urinary excretion of a vasoconstrictor arachidonic acid metabolite and a reduction in myogenic responses to increased intraluminal pressure in isolated arterioles. Unexpectedly, HHO-1 chimeric rats showed a simultaneous significant proportionate increase in somatic growth. Thus, delivery of HHO-1 gene by retroviral vector attenuates the development of hypertension and promotes body growth in spontaneously hypertensive rats.
Key Words: hypertension heme oxygenase-1 retrovirus gene transfer growth
This article has been cited by other articles:
![]() |
A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives Circulation, April 22, 2008; 117(16): 2142 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Stec, H. A. Drummond, and T. Vera Role of Carbon Monoxide in Blood Pressure Regulation Hypertension, March 1, 2008; 51(3): 597 - 604. [Full Text] [PDF] |
||||
![]() |
Z. Wang, I. Armando, L. D. Asico, C. Escano, X. Wang, Q. Lu, R. A. Felder, C. G. Schnackenberg, D. R. Sibley, G. M. Eisner, et al. The elevated blood pressure of human GRK4{gamma} A142V transgenic mice is not associated with increased ROS production Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2083 - H2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vera, S. Kelsen, L. L. Yanes, J. F. Reckelhoff, and D. E. Stec HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1472 - R1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sacerdoti, M. Bolognesi, M. Di Pascoli, A. Gatta, J. C. McGiff, M. L. Schwartzman, and N. G. Abraham Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1999 - H2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Lo, P.-J. Lu, W.-Y. Ho, M. Hsiao, and C.-J. Tseng Induction of Heme Oxygenase-1 Is Involved in Carbon Monoxide-Mediated Central Cardiovascular Regulation J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Di Noia, S. Van Driesche, F. Palmieri, L.-M. Yang, S. Quan, A. I. Goodman, and N. G. Abraham Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes J. Biol. Chem., June 9, 2006; 281(23): 15687 - 15693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, G. Li Volti, A. I. Goodman, and A. Kappas Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2468 - H2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. Quan, A. Nasjletti, M. Laniado-Schwartzman, and N. G. Abraham Heme Oxygenase-1 Gene Expression Modulates Angiotensin II-Induced Increase in Blood Pressure Hypertension, June 1, 2004; 43(6): 1221 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham, T. Kushida, J. McClung, M. Weiss, S. Quan, R. Lafaro, Z. Darzynkiewicz, and M. Wolin Heme Oxygenase-1 Attenuates Glucose-Mediated Cell Growth Arrest and Apoptosis in Human Microvessel Endothelial Cells Circ. Res., September 19, 2003; 93(6): 507 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Ndisang, L. Wu, W. Zhao, and R. Wang Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats Blood, May 15, 2003; 101(10): 3893 - 3900. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, S.-F. Yet, and M. A. Perrella Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function Experimental Biology and Medicine, May 1, 2003; 228(5): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Goodman, S. Quan, L. Yang, A. Synghal, and N. G. Abraham Functional Expression of Human Heme Oxygenase-1 Gene in Renal Structure of Spontaneously Hypertensive Rats Experimental Biology and Medicine, May 1, 2003; 228(5): 454 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Malaguarnera, S. Quan, M. R. Pilastro, N. G. Abraham, and A. Kappas Diminished Heme Oxygenase Potentiates Cell Death: Pyrrolidinedithiocarbamate Mediates Oxidative Stress Experimental Biology and Medicine, May 1, 2003; 228(5): 459 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Abraham, S. Quan, P. A. Mieyal, L. Yang, T. Burke-Wolin, C. J. Mingone, A. I. Goodman, A. Nasjletti, and M. S. Wolin Modulation of cGMP by human HO-1 retrovirus gene transfer in pulmonary microvessel endothelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1117 - L1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF] |
||||
![]() |
X.-m. Liu, G. B Chapman, K. J Peyton, A. I Schafer, and W. Durante Carbon monoxide inhibits apoptosis in vascular smooth muscle cells Cardiovasc Res, August 1, 2002; 55(2): 396 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Quan, L. Yang, N. G. Abraham, and A. Kappas Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs PNAS, October 9, 2001; 98(21): 12203 - 12208. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |